|
Market Closed -
NYSE
16:00:00 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 26.11 USD | +0.81% |
|
-8.80% | -15.77% |
| 08-14 | Oppenheimer Adjusts Pelthos Therapeutics PT to $64 From $66, Maintains Outperform Rating | MT |
| 08-13 | Pelthos Therapeutics Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Chart: Technical Analysis
Stock exchange
NYSE
PTHS 26.11 $
+0.81%
553K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| PTHS | 26.11USD | +0.81% | 553K $ | |
CBOE
| PTHS | 26.62USD | -0.26% | 11.23K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Neutral |
| Resistance | 29.5 | 29.5 | 34.4 |
| Spread/Res. | -11.49% | -11.49% | -24.10% |
| Spread/Supp. | +2.80% | +13.77% | +27.99% |
| Support | 25.4 | 22.95 | 20.4 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- PTHS Stock
- Charts Pelthos Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
